Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Holtzman

Showing results (51-60 of 292) with videos related to

Pageof 30
Sort By:
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 18, 2012
Analysis of postembryonic heart development and maturation in the zebrafish, Danio rerioCorinna Singleman, Nathalia G Holtzman
Pharmacology, Biochemistry, and Behavior|March 1, 1981
Locomotor activity in morphine-dependent and post-dependent ratsL S Brady, S G Holtzman
Life Sciences|January 1, 1992
Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxoneC A Paronis, S G Holtzman
Pharmacology, Biochemistry, and Behavior|January 1, 1987
The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcementJ S Andrews, S G Holtzman
European Journal of Pharmacology|May 14, 1992
Long term kappa-opioid receptor blockade following nor-binaltorphimineD N Jones, S G Holtzman
Psychopharmacology|January 1, 1987
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activityI B Finn, S G Holtzman
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effectsK W Locke, S G Holtzman
Blood|April 29, 2017
Genomics trumps clinical criteria in BMT? Nyet!Noa G Holtzman, Aaron P Rapoport
Drug and Alcohol Dependence|February 15, 2001
Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activityK R Powell, S G Holtzman
European Journal of Pharmacology|September 1, 1994
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interactionB E Garrett, S G Holtzman
Pageof 30

Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 18, 2012
Analysis of postembryonic heart development and maturation in the zebrafish, Danio rerioCorinna Singleman, Nathalia G Holtzman
Pharmacology, Biochemistry, and Behavior|March 1, 1981
Locomotor activity in morphine-dependent and post-dependent ratsL S Brady, S G Holtzman
Life Sciences|January 1, 1992
Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxoneC A Paronis, S G Holtzman
Pharmacology, Biochemistry, and Behavior|January 1, 1987
The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcementJ S Andrews, S G Holtzman
European Journal of Pharmacology|May 14, 1992
Long term kappa-opioid receptor blockade following nor-binaltorphimineD N Jones, S G Holtzman
Psychopharmacology|January 1, 1987
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activityI B Finn, S G Holtzman
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effectsK W Locke, S G Holtzman
Blood|April 29, 2017
Genomics trumps clinical criteria in BMT? Nyet!Noa G Holtzman, Aaron P Rapoport
Drug and Alcohol Dependence|February 15, 2001
Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activityK R Powell, S G Holtzman
European Journal of Pharmacology|September 1, 1994
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interactionB E Garrett, S G Holtzman
Pageof 30